Bupropion and dextromethorphan for treating nicotine addiction
AssigneeAntecip Bioventures II LLC
InventorHerriot Tabuteau
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods of treating neurological or psychiatric diseases or disorders, such as nicotine addiction, using a combination of bupropion and dextromethorphan. Related compositions and dosage forms are also described.
Claims17
A method of treating nicotine addiction, comprising administering a combination once daily to a human being in need thereof, wherein the combination comprises about 90 mg to about 100 mg of dextromethorphan hydrobromide, or a molar equivalent amount of another salt form of dextromethorphan or the dextromethorphan free base, and about 175 mg of the bupropion free base, or a molar equivalent amount of a salt form of bupropion.
Dependencies are inferred from the claim text.